Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Keros Therapeutics Inc KROS

Biotechnology
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel therapeutics to treat a range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-B), family of proteins. Its lead product candidate, KER-050, is being developed for the treatment of low blood cell counts, or... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KROS)

An Investigation Has Commenced on Behalf of Keros Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your KROS Losses

Accesswire 2 hours ago

Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Accesswire 3 hours ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Keros Therapeutics, Inc. (KROS) and Encourages Shareholders to Learn More About the Investigation

Accesswire 3 hours ago

Levi & Korsinsky Reminds Keros Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - KROS

Accesswire 6 hours ago

Lost Money on Keros Therapeutics, Inc. (KROS)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Accesswire 1 day ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Keros Therapeutics, Inc. - KROS 

Accesswire 1 day ago

Lost Money on Keros Therapeutics, Inc.(KROS)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

Accesswire 2 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Shareholders to Inquire about Securities Investigation

Accesswire 2 days ago

ATTENTION Keros Therapeutics, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

Accesswire 3 days ago
View More News ››

Opinion & Analysis (NDAQ:KROS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KROS)

Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Ge

NEWS: $KROS Keros Therapeutics, Inc. (KROS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the...
whytestocks - 9 days ago

Watching and waiting to see

Which direction this stock is going to go after the company made some bad news announcement the other day.It is on my watchlist now after...
coolfooldumbguy - 12 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeu

JUST IN: $KROS Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Investors to Inquire about Securities...
whytestocks - 13 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigatio

Breaking News: $KROS Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Keros Therapeutics, Inc....
whytestocks - 13 days ago

Keros Therapeutics Announces Update on the Phase 2 TROPOS Tr

News; $KROS Keros Therapeutics Announces Update on the Phase 2 TROPOS TrialKeros will host an update call and webcast today, December 12...
whytestocks - 13 days ago

Keros Therapeutics Announces Update on Enrollment in the Pha

Breaking News: $KROS Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS TrialLEXINGTON, Mass., Sept. 03, 2024...
whytestocks - September 3, 2024
View more Bullboard ››

Biosenta Inc.

Biosenta Inc.

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ...
View More »